Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)

W. Chen (Oxford, United Kingdom), C. Hardman (Oxford, United Kingdom), P. Batty (Oxford, United Kingdom), J. Luo (Oxford, United Kingdom), Y. Wu (Oxford, United Kingdom), L. Xue (Oxford, United Kingdom), G. Ogg (Oxford, United Kingdom), D. Sandham (Cambridge MA, United States of America), V. Erpenbeck (Basel, Switzerland)

Source: International Congress 2018 – Studies on the mechanisms underlying airway disease
Session: Studies on the mechanisms underlying airway disease
Session type: Thematic Poster
Number: 4401
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
W. Chen (Oxford, United Kingdom), C. Hardman (Oxford, United Kingdom), P. Batty (Oxford, United Kingdom), J. Luo (Oxford, United Kingdom), Y. Wu (Oxford, United Kingdom), L. Xue (Oxford, United Kingdom), G. Ogg (Oxford, United Kingdom), D. Sandham (Cambridge MA, United States of America), V. Erpenbeck (Basel, Switzerland). Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s). 4401

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: